The molecular tumor burden index as a response evaluation criterion in breast cancer

Circulating tumor DNA (ctDNA) is a potential biomarker of prognosis and therapeutic response. We conducted this study to explore the role of the molecular tumor burden index (mTBI) in ctDNA as a therapeutic response and prognostic biomarker in a larger cohort prospective phase III randomized multice...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Signal Transduct Target Ther
Päätekijät: Yi, Zongbi, Ma, Fei, Rong, Guohua, Liu, Binliang, Guan, Yanfang, Li, Jin, Sun, Xiaoying, Wang, Wenna, Guan, Xiuwen, Mo, Hongnan, Wang, Jiani, Qian, Haili, Xu, Binghe
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8260637/
https://ncbi.nlm.nih.gov/pubmed/34230452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-021-00662-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia